Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Drops By 23.9%

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a significant decrease in short interest during the month of February. As of February 28th, there was short interest totalling 75,900 shares, a decrease of 23.9% from the February 13th total of 99,700 shares. Approximately 4.4% of the company’s shares are short sold. Based on an average trading volume of 347,600 shares, the days-to-cover ratio is presently 0.2 days.

Hedge Funds Weigh In On Autonomix Medical

An institutional investor recently bought a new position in Autonomix Medical stock. Citadel Advisors LLC acquired a new position in shares of Autonomix Medical, Inc. (NASDAQ:AMIX) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 47,884 shares of the company’s stock, valued at approximately $180,000. Citadel Advisors LLC owned approximately 4.16% of Autonomix Medical at the end of the most recent reporting period. 10.78% of the stock is currently owned by hedge funds and other institutional investors.

Autonomix Medical Trading Up 8.9 %

Shares of AMIX opened at $2.02 on Tuesday. The stock has a market capitalization of $4.96 million, a P/E ratio of -0.16 and a beta of -5.40. The firm’s fifty day simple moving average is $2.75 and its two-hundred day simple moving average is $7.17. Autonomix Medical has a 12 month low of $1.83 and a 12 month high of $75.80.

Autonomix Medical (NASDAQ:AMIX) last issued its quarterly earnings results on Thursday, February 13th. The company reported ($1.46) EPS for the quarter. As a group, research analysts predict that Autonomix Medical will post -10 EPS for the current fiscal year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.